Changes after publication

Changes after publication

October 2018: The recommendations and section 2 were updated because the marketing authorisation for romiplostim now includes people who have not had a splenectomy.

May 2014: The recommendation wording has been updated in line with NICE's existing wording conventions and the wording used in NICE technology appraisal guidance 293: Eltrombopag for treating chronic immune (idiopathic) thrombocytopenic purpura (review of technology appraisal 205).

February 2014: minor maintenance

March 2012: minor maintenance

ISBN: 978-1-4731-3151-4

  • National Institute for Health and Care Excellence (NICE)